Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Open-market sale President and CEO sold 1,257 shares at $6.43 ($8,083)
  2. 4 Open-market sale SVP, General Counsel&Secretary sold 234 shares at $6.43 ($1,505)
  3. 4 Open-market sale EVP, Chief Development Officer sold 401 shares at $6.43 ($2,578)
  4. 4 Open-market sale EVP & Chief Medical Officer sold 408 shares at $6.43 ($2,623)
  5. 4 Open-market sale EVP & Chief Commercial Officer sold 325 shares at $6.43 ($2,090)
  6. 4 Open-market sale Chief Accounting Officer sold 23 shares at $6.43 ($148)
  7. 4 Open-market sale Chief Accounting Officer sold 12 shares at $6.78 ($81)
  8. 4 Open-market sale EVP, Chief Development Officer sold 191 shares at $4.37 ($835)
  9. 4 Open-market sale Chief Accounting Officer sold 238 shares at $4.00 ($952)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale President and CEO sold 236 shares at $7.12 ($1,680)
  18. 4 Open-market sale EVP & Chief Medical Officer sold 419 shares at $6.17 ($2,585)
  19. 4 Open-market sale President and CEO sold 245 shares at $3.74 ($916)
  20. 4 Open-market sale EVP & Chief Commercial Officer sold 3,445 shares at $6.29 ($21,669)

Page 3 of 31 · 601 filings